RFC
LAB icon

Russell Frank Company’s Standard BioTools LAB Stock Holding History

Russell Frank Company’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$9.14M Buy
+1,132,277
New +$8.17M 0.02% 1001
2015
Q2 		– Sell
-300,771
Closed -$12.7M – 3058
2015
Q1 		$12.7M Buy
300,771
+67,652
+29% +$2.67M 0.02% 775
2014
Q4 		$7.82M Sell
233,119
-988
-0.4% -$28K 0.01% 1014
2014
Q3 		$5.74M Buy
234,107
+33,052
+16% +$929K 0.01% 1198
2014
Q2 		$5.91M Buy
201,055
+65,105
+48% +$2.09M 0.01% 1218
2014
Q1 		$4.9M Buy
135,950
+7,795
+6% +$343K 0.01% 1314
2013
Q4 		$5.45M Buy
128,155
+3,505
+3% +$103K 0.01% 1177
2013
Q3 		$2.8M Buy
124,650
+124,495
+80,319% +$2.45M ﹤0.01% 1676
2013
Q2 		$3K Buy
+155
New +$2.72K ﹤0.01% 3149

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Russell Frank Company's LAB Position: Q1 2016 in Review

Russell Frank Company opened a new position in Standard BioTools (LAB) in Q1 2016: 1,132,277 shares worth $9.14M. The stake represents 0.02% of the portfolio and ranks #1001 among its holdings. This is a return to the name: Russell Frank Company previously reported a position in LAB as recently as Q1 2015.

Russell Frank Company first reported a position in LAB in Q2 2013 and has held it in 9 quarters since. The position peaked at $12.7M in Q1 2015. 100 funds tracked by Wall St. Rank hold LAB as of Q1 2016.

  • Russell Frank Company held 1,132,277 shares of Standard BioTools worth $9.14M as of Q1 2016.
  • Standard BioTools was a new Russell Frank Company position in Q1 2016.
  • Standard BioTools made up 0.02% of Russell Frank Company's portfolio in Q1 2016, its #1001 holding.
  • Russell Frank Company first reported a position in Standard BioTools in Q2 2013 and has held it in 9 quarters since.
  • Russell Frank Company's Standard BioTools position peaked at $12.7M in Q1 2015.
  • 100 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.